Aredia
Trovati 5 articoli
- Renal impairment associated with Zometa
- There is a well-known risk of deterioration in renal function with intravenous bisphosphonates administered at a rapid infusion rate. ADRAC ( Adverse Drug Reactions Advisory Committee ) has received few reports of renal impairment or failure with Pamidronate ( Aredia ) and the oral bisphosphona... (Leggi Articolo)
- Bisphosphonates associated with osteonecrosis of the jaw
- Most of the cases of osteonecrosis of the jaw are seen in oncology patients that, besides intravenous bisphosphonates, have received chemotherapy in the long term for their base disease with or without intermittent cycles of steroids. Mechanism of action begins to be recognized, the bisphosp... (Leggi Articolo)
- Risk of osteonecrosis of the jaw for patients with underlying malignant condition treated with iv bisphosphonates
- Researches at Elkhart General Hospital, in United States, have assessed the prevalence of osteonecrosis of the jaw in patients receiving bisphosphonate therapy and in those who were bisphosphonate naďve. They undertook a retrospective review of medical records of patients at the New York Harb... (Leggi Articolo)
- Therapy of osteoporosis: an update
- Osteoporosis will affect one in three women over 50 and one in five men over 50. And as the elderly population grows worldwide, by 2050 the number of women and men that will suffer from osteoporosis-related hip fractures is set to increase by 240% and 310% respectively. At the International O... (Leggi Articolo)
- Osteonecrosis of the jaw and bisphosphonates
- Bisphosphonates are drugs commonly used to prevent and treat osteoporosis in post-menopausal women. They are widely used in the management of advanced cancers that have metastasized to the bone, where the disease often causes bone pain and possibly even fractures. Several cancers can metast... (Leggi Articolo)
